Delta Variant Is Dangerous And Is Continuing To Evolve And Mutate: WHO Chief
Bharat Biotech's Covaxin vaccine was found to be 77.8 per cent effective against symptomatic Covid-19, the company announced as it concluded phase 3 clinical trials of the jab